Kristina Lamberg

Effect of delays on prognosis in patients with non-small cell lung cancer.

Gunnar Mýrdal, Mats Lambe, Gunnar Hillerdal et al. · PubMed · 2004 · 243 citations · Full text

Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Christer Sederholm, Gunnar Hillerdal, Kristina Lamberg et al. · Journal of Clinical Oncology · 2005 · 215 citations · Full text

CD99 is a novel prognostic stromal marker in non‐small cell lung cancer

Karolina Edlund, Cecilia Lindskog, Akira Saito et al. · International Journal of Cancer · 2012 · 85 citations

Immunology, Pathology, Nsclc Samples +18

Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients

Daniel Brattström, Michael Bergqvist, Patrik Hesselius et al. · Lung Cancer · 2002 · 68 citations

Tumor Biology, Poorer Survival, Medicine +10

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

Andrea Koch, Bengt Bergman, Erik Holmberg et al. · European Journal of Cancer · 2011 · 61 citations

Medicine, Pathology, Bronchial Neoplasm +7